Summary
Vascular responsiveness to vasoactive eicosanoids as well as vascular prostacyclin and thromboxane production was investigated in 7–10 weeks alloxan-diabetic rats. Aortic rings from diabetic rats exhibited increased responsiveness to carbocyclic thromboxane A2, a thromboxane analogue, when compared to control rat aortae. Isolated perfused hearts of diabetic rats showed increased vascular responsiveness to 9,11-methanoepoxy PGH2 (U-46619), an endoperoxide analogue. Diabetes resulted in a reduction in prostacyclin generation by isolated incubated aortae which was overcome by the addition of arachidonic acid but not by homogenization of incubated aortic tissue. In contrast, prostacyclin, but not thromboxane, generation was elevated in isolated perfused hearts of diabetic animals in response to moderate doses of arachidonic acid, but at high doses of arachidonate, more thromboxane was formed by perfused hearts of diabetic rats. These results suggest that different vessels can either increase or decrease their prostaglandin production in response to diabetes. The alterations in prostanoid production may be due to differential changes in prostacyclin and thromboxane synthesis in vessels which, in turn, may be related to the changes in vascular responsiveness.
Article PDF
Similar content being viewed by others
References
Carreras LO, Chamone DAF, Klerckx P, Vermylen J (1980) Decreased vascular prostacyclin (PGI2) in diabetic rats. Stimulation of PGI2 release in normal and diabetic rats by the antithrombotic compound BAY g 6575. Thromb Res 19: 663–670
Czuez RT, Wenger TL, Kunos G, Szentivany M (1973) Changes of adrenergic reaction pattern in experimental diabetes mellitus. Endocrinology 93: 752–755
Gerrard JM, Stuart MJ, Rao GHR, Steffes MW, Mauer SM, Brown DM, White JG (1980) Alteration in the balance of prostaglandin and thromboxane synthesis in diabetes. J Lab Clin Med 95: 950–956
Halushka PV, Rogers RC, Loadholt CB, Colwell JA (1981) Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med 97: 87–96
Hamberg M, Svensson J, Samuelsson B (1975) Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72: 2991–2996
Harrison HE, Johnson M (1981) Vascular prostacyclin release and metabolic derangement in diabetes. Horm Metab Res [Suppl 11]: 43–49
Ingerman-Wojenski C, Silver MJ, Smith JB, Macarak E (1981) Bovine endothelial cells in culture produce thromboxane as well as prostacyclin. J Clin Invest 67: 1292–1296
Lagarde M, Burtin M, Berciaud P, Blanc M, Velardo B, Dechavanne M (1980) Increase of platelet thromboxane A2 formation and of its plasma half-life in diabetes mellitus. Thromb Res 19: 823–830
Lefer AM, Ogletree ML, Smith JB, Silver MJ, Nicolaou KC, Barnette WE, Gasic GP (1978) Prostacyclin: profile of a potentially valuable agent for preserving jeopardized myocardial tissue in acute myocardial ischemia. Science 200: 52–54
Lewy RI, Wiener L, Walinsky P, Lefer AM, Silver MJ, Smith JB (1981) Thromboxane release during pacing induced angina pectoris: Possible vasoconstrictor influence on the coronary vasculature. Circulation 61: 1165–1171
Moncada S, Vane JR (1977) The discovery of prostacyclin (PGX). A fresh insight into arachidonic acid metabolism. In: Kharasch N, Fried J (eds) Interscience prostaglandin symposium, Academic Press, New York, San Francisco, London, pp. 155–177
Owen MP, Carrier GO (1979) Alteration in vascular smooth muscle sensitivity to vasoconstrictor agents by streptozotocin induced diabetes. Proc West Pharmacol Soc 22: 363–366
Palik I, Hadhazy P, Magyar K, Malomvolgyi B, Wagner M, Pogatsa G (1981) Effects of prostaglandins Fα, I2, and indomethacin on isolated coronary arteries from healthy and alloxan-diabetic dogs. Experientia 37: 863–864
Pfaffman MA, Hilman R, Darby A (1980) Contractile and relaxing activity of arterial smooth muscle from streptozotocin-diabetic rats. Res Comm Chem Pathol Pharm 30: 283–298
Prasad D, Turlapaty MV, Hiim G, Altura BM (1980) Vascular responsiveness and serum biochemical parameters in alloxan diabetes mellitus. Am J Physiol 239: E412-E421
Raabo E, Terkildsen TC (1960) On the enzymatic determination of blood glucose. Scand J Clin Lab Invest 12: 402–406
Rogers SP, Larkins RG (1981) Production of 6-oxo-prostaglandin F1α by rat aorta. Influence of diabetes, insulin treatment, and caloric deprivation. Diabetes 30: 935–939
Rosen P, Schrör K (1980) Increased prostacyclin release from perfused hearts of acutely diabetic rats. Diabetologia 18: 391–394
Samuelsson B, Goldyne M, Granstrom E, Hamberg M, Hammarstrom S, Malmsten C (1978) Prostaglandins and thromboxanes. Annu Rev Biochem 47: 997–1029
Schernthaner G, Sinzinger H, Silberbauer K, Freyler H, Muhlhauser I, Kaliman J (1981) Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet specific proteins in diabetes mellitus. Horm Metab Res [Suppl 11]: 33–43
Silberbauer K, Clopath P, Sinzinger H, Schernthaner G (1980) Effect of experimentally induced diabetes on swine vascular prostacyclin (PGI2) synthesis. Artery 8: 30–36
Sterin-Borda L, Borda ES, Gimeno MF, Hazpari MA, del Castillo E, Gimeno AL (1982) Contractile activity and prostacyclin generation in isolated coronary arteries from diabetic dogs. Diabetologia 22: 56–59
Sterin-Borda L, Gimeno M, Borda E, del Castillo E, Gimeno AL (1981) Prostacyclin (PGI) and U-46619 stimulate coronary arteries from diabetic dogs and their action is influenced by inhibitors of prostaglandin biosynthesis. Prostaglandins 22: 267–278
Sullivan S, Sparks HV (1979) Diminished contractile response of aortas of diabetic rabbits. Am J Physiol 236: H 301-H 306
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roth, D.M., Reibel, D.K. & Lefer, A.M. Vascular responsiveness and eicosanoid production in diabetic rats. Diabetologia 24, 372–376 (1983). https://doi.org/10.1007/BF00251827
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00251827